Home » Topics » BioWorld Science

BioWorld Science
RSS

Lipimetix sublicenses Apo E mimetic peptide platform to Anji

May 11, 2018

Phase III GALATHEA trial of Fasenra in COPD does not meet primary endpoint

May 11, 2018

FDA advisory committee votes in favor of Waylivra for familial chylomicronemia syndrome

May 11, 2018

KemPharm reports topline data from human abuse potential trial with KP-415 prodrug

May 11, 2018

CARB-X supports Talis' development of diagnostics to detect chlamydia and gonorrhea

May 11, 2018

SymBio enters joint research agreement with Keio University to evaluate Treakisym for SLE

May 11, 2018

Researchers present nanoencapsulated hepatocyte enzymes to fight alcohol intoxication

May 11, 2018

Phase I study of AVB-S6-500 demonstrates proof of mechanism

May 11, 2018

FDA identifies deficiencies during NDA review of Methylene Blue MMX

May 11, 2018

Lilly to acquire ARMO BioSciences

May 11, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...